Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MAT Recovery Centers provides outpatient addiction and mental health treatment using FDA-approved medications such as buprenorphine and naltrexone. Their approach integrates medication-assisted treatment with advanced technologies including genetic testing, AI-driven risk assessment tools, telemedicine platforms for remote care access, and innovative detox devices. The company emphasizes individualized care plans combining medical monitoring with behavioral therapies to support long-term recovery. Clinical results are described as positive by patient testimonials but no formal trial data are published.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MAT Recovery Centers.